Department of Preventive Medicine, Korea University, Seoul 02841, Korea.
College of Medicine, Hallym University, Chuncheon 24252, Korea.
J Clin Endocrinol Metab. 2023 Jul 14;108(8):e502-e511. doi: 10.1210/clinem/dgad083.
Population-based studies on the familial aggregation of Graves disease (GD) are scarce and gene-environment interactions are not well-studied.
We evaluated the familial aggregation of GD and assessed interactions between family history and smoking.
Using the National Health Insurance database, which includes information on familial relationships and lifestyle risk factors, we identified 5 524 403 individuals with first-degree relatives (FDRs). Familial risk was calculated using hazard ratios (HRs), comparing the risk of individuals with and without affected FDRs. Interactions between smoking and family history were assessed on an additive scale using relative excess risk due to interaction (RERI).
The HR among individuals with affected FDRs was 3.39 (95% CI, 3.30-3.48) compared with those without affected FDR, and among individuals with affected twin, brother, sister, father, and mother, the HRs were 36.53 (23.85-53.54), 5.26 (4.89-5.66), 4.12 (3.88-4.38), 3.34 (3.16-3.54), and 2.63 (2.53-2.74), respectively. Individuals with both a positive family history and smoking had an increased risk of disease (HR 4.68) with statistically significant interaction (RERI 0.94; 95% CI, 0.74-1.19). Heavy smokers with a positive family history showed a nearly 6-fold increased risk, which was higher than moderate smoking, suggesting a dose-response interaction pattern. Current smoking also showed a statistically significant interaction with family history (RERI 0.52; 95% CI, 0.22-0.82), while this was not observed for former smoking.
A gene-environment interaction can be suggested between smoking and GD-associated genetic factors, which diminishes after smoking cessation. Smokers with a positive family history should be considered a high-risk group and smoking cessation should be advised.
基于人群的 Graves 病(GD)家族聚集性研究很少,基因-环境相互作用也尚未得到充分研究。
我们评估了 GD 的家族聚集性,并评估了家族史与吸烟之间的相互作用。
利用包含家族关系和生活方式危险因素信息的全民健康保险数据库,我们确定了 5524403 名一级亲属(FDR)个体。使用风险比(HRs)计算家族风险,将有和无受影响 FDR 的个体的风险进行比较。使用交互超额相对风险(RERI)在加性尺度上评估吸烟和家族史之间的相互作用。
与无受影响 FDR 的个体相比,有受影响 FDR 的个体的 HR 为 3.39(95%CI,3.30-3.48),而有受影响双胞胎、兄弟、姐妹、父亲和母亲的个体的 HR 分别为 36.53(23.85-53.54)、5.26(4.89-5.66)、4.12(3.88-4.38)、3.34(3.16-3.54)和 2.63(2.53-2.74)。同时具有阳性家族史和吸烟史的个体疾病风险增加(HR 4.68),且存在统计学显著的交互作用(RERI 0.94;95%CI,0.74-1.19)。有阳性家族史的重度吸烟者患病风险增加近 6 倍,高于中度吸烟者,提示存在剂量-反应交互作用模式。目前吸烟与家族史之间也存在统计学显著的交互作用(RERI 0.52;95%CI,0.22-0.82),而既往吸烟则没有。
可以推测吸烟与 GD 相关遗传因素之间存在基因-环境相互作用,这种相互作用在戒烟后会减弱。有阳性家族史的吸烟者应被视为高危人群,并建议其戒烟。